Use Of Maximal Dosage Renin-Angiotensin-Aldosterone System Inhibitors In A Real Life Population Of Complicated Type 2 Diabetes – Contraindications And Opportunities [PDF]
, 2022 Christina M. Gant +6 more
openalex +1 more source
Hemodynamic changes in pregnancies with impaired fetal growth: A systematic review and meta‐analysis
Acta Obstetricia et Gynecologica Scandinavica, EarlyView.Maternal cardiovascular adaptation is altered in pregnancies complicated by impaired fetal growth. From the second trimester onwards, lower cardiac output and increased total peripheral vascular resistance emerge, highlighting the need for early hemodynamic monitoring and potential interventions in at‐risk pregnancies.
Britt M. J. G. Kempener +9 more
wiley +1 more source
Screening for primary aldosteronism in 1,181 Swedish primary care patients with hypertension
Frontiers in EndocrinologyObjectivePrimary aldosteronism (PA) is a common cause of hypertension. It entails elevated morbidity and mortality that do not sufficiently improve with conventional antihypertensive therapy.
Nikita Makhnov +13 more
doaj +1 more source
Cardiorenal disease development under chronic renin–angiotensin–aldosterone system suppression
, 2012 Pantelis Sarafidis, Luís M. Ruilope
openalex +2 more sources
Salt and aldosterone do not get along with each other: implication of mineralocorticoid receptors in the profibrotic action of aldosterone [PDF]
, 2011 Decio Armanini +2 more
openalex +1 more source
Hypokalemic rhabdomyolysis: a rare manifestation of primary aldosteronism [PDF]
, 2015 Rhabdomyolysis is a rare presentation of hypokalemia, although muscle weakness is a well-known manifestation of hypokalemia. Primary aldosteronism is characterized by hypertension, suppressed plasma renin activity, increased aldosterone excretion and ...
CONCISTRE, ANTONIO +9 more
core
British Journal of Pharmacology, EarlyView.Background and Purpose Cyclic guanosine monophosphate (cGMP) is a ubiquitous second messenger involved in human (patho‐)physiology. Phosphodiesterase 5 (PDE5) is a major cGMP hydrolyzing enzyme in many cell types including vascular smooth muscle cells (VSMCs). Several highly selective PDE5 inhibitors are in clinical use. However, there are currently no
Kürsat Kirkgöz +8 more
wiley +1 more source
Proceedings of the Royal Society of Medicine, 1956 M D, MILNE, R C, MUEHRCKE
openaire +4 more sources
The role of renin-angiotensin aldosterone system related micro-ribonucleic acids in hypertension
, 2015 Huibo Wang, Jun Yang
openalex +2 more sources
Prioritising research on endocrine disruption in the marine environment: a global perspective
Biological Reviews, EarlyView.ABSTRACT A healthy ocean is a crucial life support system that regulates the global climate, is a source of oxygen and supports major economic activities. A vast and understudied biodiversity from micro‐ to macro‐organisms is integral to ocean health.
Patricia I. S. Pinto +23 more
wiley +1 more source